Samsung Biologics
207940.KS
#478
Rank
NZ$89.46 B
Marketcap
NZ$1,844
Share price
-1.45%
Change (1 day)
24.95%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): NZ$43.13

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is NZ$45.68. In 2025 the company made an earnings per share (EPS) of NZ$33.85 an increase over its 2024 EPS that were of NZ$18.96.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$43.1327.41%
2025NZ$33.8578.53%
2024NZ$18.9611.34%
2023NZ$17.032.67%
2022NZ$16.5983.43%
2021NZ$9.0449.14%
2020NZ$6.0626.39%
2019NZ$4.80-12.58%
2018NZ$5.49-320.64%
2017NZ-$2.49-46.78%
2016NZ-$4.67-105.09%
2015NZ$91.87-1089.67%
2014NZ-$9.28